EUVIMEDEUVIMED entdecken
Crossref

Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study

Carlos Quintanilla-Bordás, Matías Fernández-Patón, Amadeo Ten, Cristina Ferrer-Pardo, Sara Carratala-Bosca, Jéssica Castillo-Villalba, Laura Cubas-Núñez, Raquel Gasqué-Rubio, Laura Verdini-Martínez, Francisco Pérez-Miralles, Luís Martí-Bonmatí, Bonaventura Casanova

Neurological Sciences · 2025

DOI: 10.1007/s10072-024-07921-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, 2025. Verfasst von Carlos Quintanilla-Bordás und 11 weiteren Autor:innen. Beteiligte Einrichtung: Neuroimmunology Unit, La Fe University and Polytechnic Hospital, Avda. Fernando Abril Martorell, 106, Valencia, 46026, Spain. carlosqb@gmail.com. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron-Emission Tomography, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Chronic Progressive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with multiple sclerosis (MS) may remain in a relapsing-remitting (RRMS) course despite long-standing disease, while others will develop secondary progression (SPMS). Chronic inflammation and changes in the blood-brain barrier resulting in perturbed glucose metabolism may account for these differences. PET-MRI with kinetic analysis of 2-deoxy-2(18 F)fluoro-d-glucose (18 F-FDG) provides insight into glucose metabolism and has proven useful in several chronic inflammatory diseases. However, to our knowledge, it has never been studied in MS. OBJECTIVE: To explore potential differences in glucose distribution kinetics among individuals with long-standing SPMS and RRMS using dynamic 18-F-FDG PET-MRI. METHODS: Dynamic 18-F-FDG PET-MRI scans were obtained in 11 patients with long-standing MS: 4 with RRMS and 7 with SPMS. Kinetic analysis of PET data was performed using a three-compartment model equation that represents plasma, tissue and 18 F-FDG phosphorylation. Individual rate constants of 18-F-FDG across the compartments were calculated. RESULTS: Patients with SPMS exhibited a trend towards an increased net influx rate of glucose (p = 0.059) and an increased rate constant representing glucose phosphorylation. Together, the data suggest increased uptake of glucose and glycolysis in these patients. CONCLUSION: Dynamic 18 F-FDG PET-MRI is a feasible technique that may show information in vivo of glucose metabolism in MS. Although preliminary data suggest a potential radiological marker of progression in MS, further studies are required to confirm this hypothesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Positron-Emission TomographyMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic ProgressiveBrainHumansPilot ProjectsFemaleMaleAdultMiddle AgedMagnetic Resonance ImagingGlucoseRadiopharmaceuticalsDisease Progression

Stichwörter der Autor:innen

18 F-FDG kinetic analysisGlucose metabolismMultiple sclerosisSecondary progressive multiple sclerosis

Substanzen

Fluorodeoxyglucose F18GlucoseRadiopharmaceuticals

Autor:innen und Institutionen

  • Neuroimmunology Unit, La Fe University and Polytechnic Hospital, Avda. Fernando Abril Martorell, 106, Valencia, 46026, Spain. carlosqb@gmail.com.
  • Grupo de Investigación Biomédica de Imagen, Health Research Institute Hospital La Fe, Valencia, Spain.
  • Neuroimmunology Unit, La Fe University and Polytechnic Hospital, Avda. Fernando Abril Martorell, 106, Valencia, 46026, Spain.
  • Neuroimmunology Unit, Health Research Institute Hospital La Fe, Valencia, Spain.
  • Medical Imaging department, La Fe University and Polytechnic Hospital, Valencia, Spain.

Zitieren

APA

Quintanilla-Bordás, C., Fernández-Patón, M., Ten, A., Ferrer-Pardo, C., Carratala-Bosca, S., Castillo-Villalba, J., Cubas-Núñez, L., Gasqué-Rubio, R., Verdini-Martínez, L., Pérez-Miralles, F., Martí-Bonmatí, L., & Casanova, B. (2025). Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study. Neurological Sciences. https://doi.org/10.1007/s10072-024-07921-x

Vancouver

Quintanilla-Bordás C, Fernández-Patón M, Ten A, Ferrer-Pardo C, Carratala-Bosca S, Castillo-Villalba J, et al. Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study. Neurological Sciences. 2025. doi:10.1007/s10072-024-07921-x

BibTeX
@article{QuintanillaBords2025,
  author = {Quintanilla-Bordás, Carlos and Fernández-Patón, Matías and Ten, Amadeo and Ferrer-Pardo, Cristina and Carratala-Bosca, Sara and Castillo-Villalba, Jéssica and Cubas-Núñez, Laura and Gasqué-Rubio, Raquel and Verdini-Martínez, Laura and Pérez-Miralles, Francisco and Martí-Bonmatí, Luís and Casanova, Bonaventura},
  title = {Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study},
  journal = {Neurological Sciences},
  year = {2025},
  doi = {10.1007/s10072-024-07921-x}
}
Kostenlos starten →